A Dose Finding Study to Treat Bone Tumor(s)

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC), Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT06008483
Phase: PHASE1
Trial Summary: To determine the Maximum Tolerated Dose (MTD) of CycloSam®, Samarium-153-DOTMP (Sm-153-DOTMP), a radiopharmaceutical that delivers radiation to the bone when injected, given as a tandemly administere – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): QSAM Therapeutics, Inc.
Acronym:

Pin It on Pinterest